The Tenth Case of International MDT Conducted Between ZUCH and BCH
At 8 am on August 25th, Beijing time, the specialists of the Children’s Hospital of Zhejiang University School of Medicine (ZUCH) and Boston Children's Hospital (BCH) met together by remote video for consulting a rare case of systemic vasculitis. This MDT team includes Dr. Fu Junfen, the Executive Vice President, Dr. Lu Meiping, Director of the Department of Rheumatology and Immunology, Dr. Xu Xuefeng, Deputy Director of the Department of Rheumatology and Immunology, Zheng Rongjun, case reporter, Dr. Du Lizhong and Dr. Tang Yongmin, two academic leaders of Neonatology and Hematology&Oncology of ZUCH, and Dr. Pui Lee, Assistant Professor of Pediatrics of Harvard University, and Mr. Alan Yen, Director of Business Development of International Health services of BCH .
This is the tenth complicated case for the international MDT consultation between ZUCH and BCH since last December. The case is a 7-year-old boy with a rare and critical condition. After the case report, the experts of two hospitals discussed about the possible consideration of COPA syndrome, the use of JAK inhibitors, and how to gradually reducing the amount of hormone drugs based on the patient’s situation, etc.
Mr. Yen says, “Boston Children’s Hospital has a long history of supporting the Chinese pediatric medical community dating back more than 30 years. By establishing cooperation with leading Chinese hospitals such as ZUCH, Boston Children’s is able to share the clinical approach and experience with specialists at ZUCH, promote exchange of best practices, increase learning and understanding between two medical teams and provide benefit to patients and families.”
Dr. Fu Junfen concludes, “ Both BCH and ZUCH have a strong interest in promoting pediatric medicine across the globe in order to ensure the health of all children. So far, ten complicated cases have been consulted, and many of them have achieved good outcomes. I hope more specialties of our hospital will join the talk with specialists of BCH to promote the development of pediatric medicine.”